Core Viewpoint - The issue of excessively high prices for traditional Chinese medicine (TCM) has not been resolved, as evidenced by recent government actions targeting price adjustments for numerous TCM products across various provinces [1][2][4]. Group 1: Price Governance Actions - The Guangxi Drug Procurement Service Platform announced a price adjustment for 169 high-priced TCMs, requiring companies to complete adjustments by July 30 [1]. - Multiple provinces, including Jilin, Henan, and Jiangsu, have initiated price governance for TCMs, with notable products like An Gong Niu Huang Wan and Ban Lan Gen Granules being included [2]. - Jilin Province identified 52 TCMs with significant price discrepancies, with price differences ranging from 10 to over 117 times the minimum daily cost [2][3]. Group 2: Price Discrepancies and Examples - The price of TCMs is significantly higher compared to chemical drugs, with some products showing price differences exceeding 100 times [2]. - For instance, the price of Yuan Hu Zhi Tong Pian from Chongqing Xieran Pharmaceutical Co. is 110 yuan, with a daily cost of 45.83 yuan, leading to a price difference of 117.51 times the minimum daily cost [2][3]. Group 3: Historical Context and Ongoing Issues - The problem of high TCM prices has been persistent, with a 2009 study indicating that out of 93 high-priced TCMs, only 6 had prices close to their theoretical retail prices [4]. - Factors contributing to high prices include an inadequate pricing mechanism, numerous distribution channels, and commercial bribery in the pharmaceutical sector [4]. Group 4: Regulatory Developments - The National Medical Insurance Administration has initiated ongoing price governance for TCMs, with 28 provinces improving their drug pricing rules [4][5]. - The governance focuses on "average daily treatment costs," with penalties for products exceeding set price thresholds [5]. Group 5: Market Adaptations and Future Strategies - TCM companies are adapting to regulatory changes by exploring new profit avenues outside traditional markets, such as health products and wellness items [8]. - Companies like Li Shizhen and Tong Ren Tang are launching health-oriented products, indicating a shift in focus towards future growth opportunities [8][9].